The decreased CD3 and CD8 levels and the increased CD4/CD8 ratio were discovered in the s acute pulmonary embolism and chronic thromboembolic pulmonary hypertension (CTEPH) patients, meaning the dysfunction of CD3+ CD8+ T Cell immunity (50). This evidence concerns the gene CD4 and chronic thromboembolic pulmonary hypertension.